Community-acquired Acinetobacter baumannii pneumonia

K Bachoumas; C Lebert; J C Lacherade; J Reignier

doi:10.1016/j.medmal.2015.06.002

Community-acquired Acinetobacter baumannii pneumonia

Med Mal Infect. 2015 Aug;45(8):337-9. doi: 10.1016/j.medmal.2015.06.002. Epub 2015 Jul 2.

Authors

K Bachoumas¹, C Lebert², J C Lacherade², J Reignier²

Affiliations

¹ Service de réanimation médicale, Hôpital de La Roche-sur-Yon, 85000 La Roche-sur-Yon, France. Electronic address: cbachoumas@gmail.com.
² Service de réanimation médicale, Hôpital de La Roche-sur-Yon, 85000 La Roche-sur-Yon, France.

PMID: 26141128
DOI: 10.1016/j.medmal.2015.06.002

No abstract available

Keywords: Acinetobacter baumannii; Acute respiratory failure; Community-acquired pneumonia; Insuffisance respiratoire aiguë; Pneumopathie communautaire.

Publication types

Case Reports
Letter

MeSH terms

Acinetobacter Infections / complications
Acinetobacter Infections / diagnosis
Acinetobacter Infections / drug therapy
Acinetobacter Infections / microbiology*
Acinetobacter baumannii / drug effects
Acinetobacter baumannii / isolation & purification*
Alcoholism / complications
Anti-Bacterial Agents / therapeutic use
Community-Acquired Infections / complications
Community-Acquired Infections / diagnosis
Community-Acquired Infections / drug therapy
Community-Acquired Infections / microbiology*
Delayed Diagnosis
Drug Resistance, Multiple, Bacterial
Fatal Outcome
Humans
Male
Middle Aged
Opportunistic Infections / diagnosis
Opportunistic Infections / drug therapy
Opportunistic Infections / microbiology
Pneumonia, Bacterial / complications
Pneumonia, Bacterial / diagnosis
Pneumonia, Bacterial / drug therapy
Pneumonia, Bacterial / microbiology*
Practice Guidelines as Topic
Respiratory Distress Syndrome / etiology
Risk Factors
Smoking / adverse effects

Substances

Anti-Bacterial Agents